401 Phase 1/2 study of novel HER2-targeting, TLR7/8 immune-stimulating antibody conjugate (ISAC) BDC-1001 with or without immune checkpoint inhibitor in patients with advanced HER2-expressing solid tumors

• Marcin Kowanetz,
• Manish Sharma,
• Jeeyun Lee,
• Leisha Emens,
• Keun-Wook Lee,
• Yoon-Koo Kang,
• Paula Pohlmann,
• Glenn Hanna,
• Ecaterina Ileana Dumbrava,
• Daniel Catenacci,
• Dejan Juric,
• Bob Li,
• Kathleen Moore,
• Mark Pegram,
• Antoinette Tan,
• Shelley Ackerman,
• Heidi LeBlanc,
• David Dornan,
• Michael Alonso,
• Edith Perez

Affiliations

Marcin Kowanetz

Aff1 grid.418158.10000000405344718Genentech, Inc. San Francisco CA USA

Manish Sharma

4 Department of Emergency Medicine, NewYork-Presbyterian Queens, Flushing, New York, USA

Jeeyun Lee

Aff211 grid.264381.a000000012181989XSamsung Medical CenterSungkyunkwan University School of Medicine Seoul South Korea

Leisha Emens

Aff501 grid.21107.350000000121719311Johns Hopkins University School of Medicine Baltimore MD USA

Keun-Wook Lee

Aff10 0000 0004 0470 5905grid.31501.36Seoul National University Bundang HospitalSeoul National University College of Medicine Seongnam South Korea

Yoon-Koo Kang

Aff6 0000 0004 0533 4667grid.267370.7Asan Medical CenterUniversity of Ulsan College of Medicine Seoul South Korea

Paula Pohlmann

7Georgetown University, Washington, DC, USA

Glenn Hanna

2Dana-Farber Cancer Institute, Boston, MA, USA

Ecaterina Ileana Dumbrava

2The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Daniel Catenacci

4University of Chicago, Chicago, IL, USA

Dejan Juric

7Massachusetts General Hospital, Boston, MA, USA

Bob Li

11Memorial Sloan Kettering Cancer Center, New York, NY, USA

Kathleen Moore

12Stephenson Cancer Center, Oklahoma City, OK, USA

Mark Pegram

13Stanford University, Stanford, CA, USA

Antoinette Tan

17Levine Cancer Institute, Atrium Health, Charlotte, NC, USA

Shelley Ackerman

19Bolt Biotherapeutics, Redwood City, CA, USA

Heidi LeBlanc

19Bolt Biotherapeutics, Redwood City, CA, USA

David Dornan

19Bolt Biotherapeutics, Redwood City, CA, USA

Michael Alonso

19Bolt Biotherapeutics, Redwood City, CA, USA

Edith Perez

19Bolt Biotherapeutics, Redwood City, CA, USA